Back to results
US 2012/0258446 A1Published application
Universal Multi-Variant Detection System
AssigneeNew York Blood Center, Inc.
InventorsLinda Andrus, Carmen Nicola Nichols
Life of this patent
Estimating the term…
Abstract
The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
Claims22
A kit for the detection of a target nucleic acid molecule in a sample, wherein the target nucleic acid molecule is known to have variant sequences, comprising:
- (i) a set of nose-to-nose primers comprising a forward primer and a reverse primer, each comprising a sequence of nucleotides and wherein the forward and reverse primers are characterized in that a nucleotide at the 3′ end of the reverse primer hybridizes with:
- (i) a nucleotide at the 5′ end of a forward primer extension product or;
- (ii) a nucleotide separated from the nucleotide at the 5′ end of the forward primer extension product by a gap;
- and a nucleotide at the 3′ end of the forward primer hybridizes with:
- (i) a nucleotide at the 5′ end of a reverse primer extension product or;
- (ii) a nucleotide separated from the nucleotide at the 5′ end of the reverse primer extension product by the gap;
- (ii) reagents for performing a primer extension chain reaction and;
- (iii) a self-altering signal-generating probe which detects the presence of primer amplification products, wherein the probe comprises a first nucleic acid sequence attached to a reporter moiety capable of generating a detectable signal;
- a second nucleic acid sequence attached to an interactive moiety capable of altering the signal of the reporter moiety;
- and a probe sequence which connects the first and second nucleic acid sequences.
7 more elements
Dependencies are inferred from the claim text.